abstract |
The present invention relates to a method of inhibiting the growth of cells, particularly cancer cells that overexpress Wnt2. The method comprises contacting a cell with a factor that binds to Wnt2 mRNA or Wnt2 protein, interferes with Wnt2 signaling, or inhibits Wnt2 protein binding to another protein, such as a Frizzled receptor. including. |